<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7093072/results/search/country/results.xml">
  <result pre="COVID-19 patients person-1ZhuShudong1*person-2GuoXialing1person-3GearyKyla2person-4ZhangDianzheng2[], [], Shudong Zhu, PhD, Argus Pharmaceuticals, Changsha," exact="China" post="Address: 8 LuJing Ave., Changsha, China; Email: 1125537080@qq.com :"/>
  <result pre="Since the beginning of December 2019, numerous hospitals in Wuhan," exact="China" post="have reported an increasing number of patients with pneumonia"/>
  <result pre="infection. 2. Nucleotide analogs The first case of COVID-19 in" exact="the United States" post="was confirmed on January 20, 2020, by qPCR assay"/>
  <result pre="2. Nucleotide analogs The first case of COVID-19 in the" exact="United States" post="was confirmed on January 20, 2020, by qPCR assay"/>
  <result pre="and/or II clinical trials3,4. Therefore, Gilead has been working with" exact="China" post="since February 2020 to conduct a phase 3 randomized,"/>
  <result pre="are undergoing clinical trials. Fapivir is a drug approved in" exact="Japan" post="for flu treatment. Figure 1 The structure of remdesivir,"/>
  <result pre="in Xiangya Hospital in China, which has been registered in" exact="the US" post="clinical trial database10. 5. Lopinavir/ritonavir Lopinavir/ritonavir is a combination"/>
  <result pre="treatment of COVID-19, especially since darunavir has been approved in" exact="China" post="since 2018 for HIV treatment. 6. Plasma The company"/>
  <result pre="function. Clinical trials on this antibody are now underway in" exact="China" post="to potentially reduce both lung damage and death caused"/>
  <result pre="the agenda. A search with the word &quot;COVID-19&quot; in the" exact="China" post="Clinical Trials Registry (http://www.chictr.org.cn) revealed that 218 clinical trials"/>
 </snippets>
</snippetsTree>
